Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 41INDUSTRY 5NIH 2NETWORK 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Sleep Wake Disorders 1Fatigue 1Depression 1Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Metformin × Breast × Clear all
NCT01101438 2023-09-13

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

Canadian Cancer Trials Group

Phase 3 Completed
3,649 enrolled 17 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01286233 2015-09-09

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

NSABP Foundation Inc

Unknown
394 enrolled
Breast

Breast Neoplasms, Depression, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡